EDB recommends

About company Contact
Příluky 386,
76001 Zlín-Příluky
Telephone: +420 577 637 111
Web: www.kkssro.cz
KKS, spol. s.r.o. is a construction company that implements orders of a larger nature. The main activity is the implementation of both civil and industrial buildings, their reconstruction, demolition and repair. We are also dedicated to the construction of all roads.

Our company offers complex construction work.

Realization, construction, buildings, construction, reconstruction:
- industrial halls
- civil
- apartments, apartments, apartments, apartments
- family houses and houses, family houses and houses
-communication, communication:
-roads, paths, sidewalks
-bridges
-utilities
-water management structures

Reconstruction, demolition, repairs:
- buildings.

Gas station.

Reg. No.: 42340802
VAT No.: CZ42340802
District: Zlínský
Country: Česká republika
Legal form: limited company
Employees: 26 - 100 employees
Turnover: 4 000 thousand - 8 000 thousand €

Telephone:
+420 577 637 111

Email:
[email protected]

QR kód firmy KKS, spol. s r.o.

Route planner

Sorry, the route could not be processed.
Contact
form

Related articles

Current offers

Current articles

Pharmaceutical facilities and turnkey cleanrooms

Pharmens s.r.o.

The Pharmens company provides complex services connected to projects, engineering activities, supplies, assemblies, putting equipment and machines into operation, validations of cleanrooms, technological and manufacturing processes for pharmaceutical (production of liquid and solid pharmaceutical forms, i.e., injection preparations, for instance in the field of cytostatic preparations, insulin, infusions, injection products, medicinal aerosols, ointments, gels, pills and suppositories) and laboratory facilities in accordance with the SVP, GMP and FDA norms. If you want a professional and functional implementation or reconstruction of pharmaceutical facilities, do not hesitate and contact the Pharmens company, which is engaged in the capital construction management, from preparing the investment plan up to the implementation of “turnkey“ pharmaceutical facilities.